Results 191 to 200 of about 219,336 (313)

A systematic review of ethnobotanical study in Indonesia: diversity and cultural patterns of medicinal plant use. [PDF]

open access: yesJ Ethnobiol Ethnomed
Febriyanti RM   +7 more
europepmc   +1 more source

Plants as Source of Medicines

open access: yes, 2006
Verpoorte, R., Kim, H.K., Choi, Y.H.
openaire   +2 more sources

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Central India Medicinal Plant Dataset (CIMPD). [PDF]

open access: yesData Brief
Singh RK   +5 more
europepmc   +1 more source

National strategy and action plan for medicinal and aromatic plant species [PDF]

open access: yes, 2002
Kenya Working Group on Medicinal and Aromatic Plant Species (KWG-MAPS)   +1 more
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Functional characterization of four glycosyltransferases for biosynthesis of steroidal saponins in medicinal plant <i>Paris polyphylla</i>. [PDF]

open access: yesSynth Syst Biotechnol
Subthain H   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy